Hemidesmosome complex (HD)

The hemidesmosome complex is a specialized multiprotein junctional structure essential for the stable adhesion of basal epithelial cells to the underlying basement membrane (Source: Walko et al., 2015, J Cell Sci). It consists of several key components, including transmembrane proteins such as integrin alpha-6 beta-4 and Bullous Pemphigoid Antigen 2 (BP180/Type XVII collagen), and cytoplasmic plaque proteins like Bullous Pemphigoid Antigen 1 (BP230) and plectin (Source: UniProt P15144, Q03001). These proteins bridge the intracellular keratin intermediate filament network to the extracellular matrix, providing mechanical stability to tissues like the skin, cornea, and mucosal surfaces. In clinical medicine, the hemidesmosome is a critical target in autoimmune blistering diseases, where autoantibodies against BP180 or BP230 disrupt the complex, leading to subepidermal cleavage and blister formation (Source: StatPearls, Bullous Pemphigoid). Additionally, genetic mutations in its components result in various forms of epidermolysis bullosa, characterized by extreme skin fragility (Source: NIH, Genetics Home Reference). Current therapeutic approaches primarily involve systemic immunosuppression or biologics like Rituximab and Dupilumab to mitigate the autoimmune attack against these structural proteins, while regenerative medicine and gene therapies are being explored to address hereditary defects in the complex (Source: Schmidt & Zillikens, 2013, Lancet).

Other names

HemidesmosomeDermal-epidermal junction complexBasal junctional complexType I hemidesmosomeType II hemidesmosome